Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.

Media Press Kit

We at hVIVO (formerly Open Orphan plc) are a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.

Please see some useful resources below including the latest hVIVO plc investor presentation, approved company descriptions, and images which can be used for editorial purposes as long as the connection to hVIVO / Venn LIfe Sciecnes / FluCamp is clearly recognisable. Commercial use is prohibited.

Open Orphan logo on March 2022 presentation

Download Latest Presentation

09 Sep 2022
H1 2022 Financial Results
Download

Images - hVIVO

Download icon
Cathal Friel – Chairman hVIVO plc
(152 KB - JPG)
Download icon
Yamin Khan – Chief Executive Officer hVIVO plc
(100 KB - JPG)
Download icon
Stephen Pinkerton – Chief Financial Officer hVIVO plc
(640 KB - JPG)
Download icon
Dr Andrew Catchpole – Executive Chairman hVIVO plc
(196 KB - JPG)
Download icon
Adam French – hVIVO Director Laboratory Operations
(135 KB - JPG)
Download icon
Mariya Kalinova – Medical Director
(94 KB - JPG)
Download icon
FluCamp Nurse 1
(16.7 MB - JPG)
Download icon
hVIVO FluCamp 1
(107 KB - JPG)
Download icon
hVIVO FluCamp 2
(3 MB - JPG)
Download icon
hVIVO FluCamp 3
(3 MB - JPG)
Download icon
hVIVO FluCamp 4
(2 MB - JPG)
Download icon
hVIVO FluCamp 5
(2 MB - JPG)
Download icon
FluCamp Volunteer 1
(22 MB - JPG)
Download icon
Whitechapel Clinic Quarantine Room 1
(3 MB - JPG)
Download icon
hVIVO Lab 1
(20.9 MB - JPG)
Download icon
hVIVO Lab 2
(3 MB - JPG)
Download icon
hVIVO Lab 3
(18 MB - JPG)
Download icon
hVIVO Lab 4
(16 MB - JPG)

hVIVO Description

We at hVIVO plc (London and Euronext: HVO) are a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. We provide end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

Our fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via our Venn Life Sciences brand, and a lab offering via our hLAB brand, which includes virology, immunology biomarker and molecular testing. We offer additional clinical field trial services such as patient recruitment and clinical trial site services.

We run challenge studies in London from our Whitechapel quarantine clinic, our state-of-the-art QMB clinic with a highly specialised on-site virology and immunology laboratory, and our clinic in Plumbers Row. To recruit volunteers / patients for our studies, we leverage our unique clinical trial recruitment capacity via our FluCamp volunteer screening facilities in London and Manchester.

If you’re a potential customer, job seeker, health professional or an investor, find out how we can help you.

Contact hVIVO
chevron-down